Table 1 Primary antibodies
From: Predominance of the basal type and HER-2/neu type in brain metastasis from breast cancer
Epitope | Clone | Company | Dilution | CS |
|---|---|---|---|---|
AR | AR 441 | Dako | 1:250 | FR |
Annexin | 29 | TD | 1:1000 | DAB |
β-Catenin | 14 | TD | 1:200 | DAB |
bcl-2 | 124 | Dako | 1:150 | DAB |
bcl-6 | PG-B6p | Dako | 1:100 | FR |
CK 5/14 | LH8 | CC | 1:600 | DAB |
CK 14 | LL002 | NC | 1:50 | DAB |
CK 18 | DC-10 | NC | 1:1000 | DAB |
CK 19 | BA 17 | Dako | 1:300 | DAB |
Cyclin D1 | DCS-6 | Dako | 1:50 | DAB |
Cyclin D3 | DCS-23 | NC | 1:25 | FR |
ER | 1D5 | Dako | 1:20 | DAB |
E-cadherin | 36 | TD | 1:2400 | FR |
EGFR | — | ZM | 1:50 | FR |
Her-2/neu | Cerb-2 | Dako | 1:400 | DAB |
Ki-67 | Mib-1 | Dako | 1:250 | DAB |
PR | PgR 636 | Dako | 1:500 | DAB |
p27 | SX53GB | Dako | 1:50 | DAB |
p53 | DO-7 | Dako | 1:200 | DAB |
Skp 2 | 2C8D9 | ZM | 1:80 | DAB |
